PARK JONG IL
No ORCID on file
· 57 papers in corpus
2008
A method for stabilizing a low-molecular-weight bioactive substance and a bioactive substance-blood protein conjugate are provided to modify the low-molecular-weight bioactive substances with short in vivo half-life and low stability by ex …
2008
A method for stabilizing a low-molecular-weight bioactive substance and a bioactive substance-blood protein conjugate are provided to modify the low-molecular-weight bioactive substances with short in vivo half-life and low stability by ex …
2008
A method for stabilizing a low-molecular-weight bioactive substance and a bioactive substance-blood protein conjugate are provided to modify the low-molecular-weight bioactive substances with short in vivo half-life and low stability by ex …
2008
A method for stabilizing a low-molecular-weight bioactive substance and a bioactive substance-blood protein conjugate are provided to modify the low-molecular-weight bioactive substances with short in vivo half-life and low stability by ex …
2008
A method for stabilizing a low-molecular-weight bioactive substance and a bioactive substance-blood protein conjugate are provided to modify the low-molecular-weight bioactive substances with short in vivo half-life and low stability by ex …
2008
A method for stabilizing a low-molecular-weight bioactive substance and a bioactive substance-blood protein conjugate are provided to modify the low-molecular-weight bioactive substances with short in vivo half-life and low stability by ex …
2008
A method for stabilizing a low-molecular-weight bioactive substance and a bioactive substance-blood protein conjugate are provided to modify the low-molecular-weight bioactive substances with short in vivo half-life and low stability by ex …
2008
A method for stabilizing a low-molecular-weight bioactive substance and a bioactive substance-blood protein conjugate are provided to modify the low-molecular-weight bioactive substances with short in vivo half-life and low stability by ex …
2008
A method for stabilizing a low-molecular-weight bioactive substance and a bioactive substance-blood protein conjugate are provided to modify the low-molecular-weight bioactive substances with short in vivo half-life and low stability by ex …
2008
A method for stabilizing a low-molecular-weight bioactive substance and a bioactive substance-blood protein conjugate are provided to modify the low-molecular-weight bioactive substances with short in vivo half-life and low stability by ex …
2008
A method for stabilizing a low-molecular-weight bioactive substance and a bioactive substance-blood protein conjugate are provided to modify the low-molecular-weight bioactive substances with short in vivo half-life and low stability by ex …
2008
A method for stabilizing a low-molecular-weight bioactive substance and a bioactive substance-blood protein conjugate are provided to modify the low-molecular-weight bioactive substances with short in vivo half-life and low stability by ex …
2008
A method for stabilizing a low-molecular-weight bioactive substance and a bioactive substance-blood protein conjugate are provided to modify the low-molecular-weight bioactive substances with short in vivo half-life and low stability by ex …
2008
A method for stabilizing a low-molecular-weight bioactive substance and a bioactive substance-blood protein conjugate are provided to modify the low-molecular-weight bioactive substances with short in vivo half-life and low stability by ex …
2008
A method for stabilizing a low-molecular-weight bioactive substance and a bioactive substance-blood protein conjugate are provided to modify the low-molecular-weight bioactive substances with short in vivo half-life and low stability by ex …
2008
A method for stabilizing a low-molecular-weight bioactive substance and a bioactive substance-blood protein conjugate are provided to modify the low-molecular-weight bioactive substances with short in vivo half-life and low stability by ex …
2008
A method for stabilizing a low-molecular-weight bioactive substance and a bioactive substance-blood protein conjugate are provided to modify the low-molecular-weight bioactive substances with short in vivo half-life and low stability by ex …
2008
A method for stabilizing a low-molecular-weight bioactive substance and a bioactive substance-blood protein conjugate are provided to modify the low-molecular-weight bioactive substances with short in vivo half-life and low stability by ex …
2008
A method for stabilizing a low-molecular-weight bioactive substance and a bioactive substance-blood protein conjugate are provided to modify the low-molecular-weight bioactive substances with short in vivo half-life and low stability by ex …
2008
A method for stabilizing a low-molecular-weight bioactive substance and a bioactive substance-blood protein conjugate are provided to modify the low-molecular-weight bioactive substances with short in vivo half-life and low stability by ex …
2008
A method for stabilizing a low-molecular-weight bioactive substance and a bioactive substance-blood protein conjugate are provided to modify the low-molecular-weight bioactive substances with short in vivo half-life and low stability by ex …
2008
A method for stabilizing a low-molecular-weight bioactive substance and a bioactive substance-blood protein conjugate are provided to modify the low-molecular-weight bioactive substances with short in vivo half-life and low stability by ex …
2008
A method for stabilizing a low-molecular-weight bioactive substance and a bioactive substance-blood protein conjugate are provided to modify the low-molecular-weight bioactive substances with short in vivo half-life and low stability by ex …
2008
A method for stabilizing a low-molecular-weight bioactive substance and a bioactive substance-blood protein conjugate are provided to modify the low-molecular-weight bioactive substances with short in vivo half-life and low stability by ex …
2008
A method for stabilizing a low-molecular-weight bioactive substance and a bioactive substance-blood protein conjugate are provided to modify the low-molecular-weight bioactive substances with short in vivo half-life and low stability by ex …